Leukemias and lymphomas are estimated to contribute up to 7% of all new malignant cases in the United States.[1]
Sandra Rome, RN
Advertisement
Articles by Sandra Rome, RN
The availability of a wide variety of treatments for multiple myeloma allows healthcare providers to tailor treatments to individual patient needs, and has enabled prolonged survival of patients with the disease.
Advertisement
Latest Updated Articles
Current Diagnosis and Management of Multiple MyelomaApril 19th 2011
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
BCMA-Directed Bispecific Antibodies Navigating a New Era in Relapsed/Refractory Multiple Myeloma
3
Comparison of the 3 Most Commonly Used Modified PD-1 Inhibitors Plus Chemotherapy in Inoperable Wild-Type Non–Small Cell Lung Cancer
4
Is It Helping or Harming? A Clinician’s Guide to Cannabis Use in Oncology
5